Table 3 Wipe off recovery of dropped anticancer drug from the slipper sole
Anticancer drug | Dropped amount (μg) | Recovery (μg) | Recovery (%) | CV (%) |
|---|---|---|---|---|
CPA | 2000 | 1947.2 ± 261.5 | 97.4 ± 13.1 | 13.4 |
IFM | 1000 | 1094.6 ± 87.8 | 109.5 ± 8.8 | 8.0 |
CBDCA | 5000 | 4240.5 ± 618.2 | 84.8 ± 12.4 | 14.6 |
CDDP | 100 | 68.2 ± 11.5 | 68.2 ± 11.5 | 16.9 |
MTX | 6000 | 4890.6 ± 413.3 | 81.5 ± 6.9 | 8.5 |
5-FU | 1000 | 873.2 ± 33.4 | 87.3 ± 3.3 | 3.8 |
Ara-C | 1000 | 726.3 ± 117.3 | 72.6 ± 11.7 | 16.1 |
GEM | 300 | 300.4 ± 27.3 | 100.1 ± 9.1 | 9.1 |
ADR | 1000 | 899.4 ± 121.1 | 89.9 ± 12.1 | 13.5 |
Epi-ADR | 1000 | 475.5 ± 40.8 | 47.6 ± 4.1 | 8.6 |
PTX | 200 | 200.0 ± 18.9 | 100.0 ± 9.5 | 9.5 |
DTX | 200 | 171.1 ± 14.9 | 85.5 ± 7.4 | 8.7 |
VP-16 | 500 | 308.7 ± 46.8 | 61.7 ± 9.4 | 15.2 |
CPT-11 | 1500 | 1213.2 ± 159.5 | 80.9 ± 10.6 | 13.1 |